Covered recipient · General Payments record
KELLY DALE
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2023–2024
$6,244.52
- Reported across 64 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $3,465.00 | 1 |
| Travel and Lodging | $1,093.24 | 3 |
| Food and Beverage | $538.69 | 13 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $4,843.85 | 5 |
| ABBVIE INC. | $102.51 | 5 |
| Gilead Sciences, Inc. | $58.89 | 3 |
| Ipsen Biopharmaceuticals, Inc | $38.91 | 2 |
| Acerta Pharma LLC | $30.72 | 1 |
| Mirum Pharmaceuticals, Inc. | $22.05 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $25.02 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106980747 | CMS |
| ABBVIE INC. | $16.14 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106980749 | CMS |
| ABBVIE INC. | $26.64 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106980751 | CMS |
| ABBVIE INC. | $18.14 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106980753 | CMS |
| ABBVIE INC. | $16.57 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106980755 | CMS |
| AstraZeneca Pharmaceuticals LP | $30.72 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105889679 | CMS |
| Gilead Sciences, Inc. | $21.03 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133654972 | CMS |
| Gilead Sciences, Inc. | $19.19 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133654974 | CMS |
| Gilead Sciences, Inc. | $18.67 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133654976 | CMS |
| Ipsen Biopharmaceuticals, Inc | $18.45 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091951921 | CMS |
| Ipsen Biopharmaceuticals, Inc | $20.46 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091951923 | CMS |
| Mirum Pharmaceuticals, Inc. | $22.05 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1123326201 | CMS |
| Novo Nordisk Inc | $337.54 | 04/13/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1100291870 | CMS |
| Novo Nordisk Inc | $665.79 | 04/13/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1100496495 | CMS |
| Novo Nordisk Inc | $3,465.00 | 04/13/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1100658046 | CMS |
| Novo Nordisk Inc | $285.61 | 04/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100658400 | CMS |
| Novo Nordisk Inc | $89.91 | 04/13/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1100658524 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.